Taiwan Bio Therapeutics News and Resources

Taiwan Bio Therapeutics, Inc. and TRACT Therapeutics, Inc. have achieved a key milestone with the successful transfer of TRACT’s TregCel platform technology to Taiwan Bio’s GMP cell manufacturing facility. The partnership, established in December 2023, combines Taiwan Bio’s expertise in